Business
EcoPlus, Inc. (OTC: ECPL) Signs Letter of Intent to Acquire Longevity Formulas, a Leading Anti-Aging Nutraceutical Company
EcoPlus, Inc. (OTC: ECPL) Signs Letter of Intent to Acquire Longevity Formulas, a Leading Anti-Aging Nutraceutical Company.
About this update from Ecoplus, Inc.
[{"type":"text","content":"EcoPlus, Inc. (OTC: ECPL) Signs\r\n Letter of Intent to Acquire Longevity Formulas, a Leading Anti-Aging\r\n Nutraceutical Company\r\n\r\nSALEM, MA –October 22, 2025 – EcoPlus, Inc. (OTC: ECPL), a publicly traded holding company\r\n focused on the acquisition and growth of nutraceutical and wellness brands,\r\n today announced that it has executed a Letter of Intent (LOI) to acquire\r\n Longevity Formulas, Inc., a Scottsdale-based e-commerce company\r\n specializing in nutritional supplements and holistic products for anti-aging\r\n and overall wellness.\r\n\r\nFounded by Dr. Gary Martin, Longevity Formulas has established a\r\n trusted reputation in the health and wellness community through its proprietary\r\n formulations and outstanding customer service. \r\n\r\nUnder the terms of the LOI, EcoPlus intends to acquire\r\n substantially all of Longevity Formulas’ assets — including intellectual\r\n property, product formulations, customer databases, e-commerce platforms, and\r\n goodwill, subject to final due diligence and execution of a definitive purchase\r\n agreement.\r\n\r\n“Longevity Formulas represents exactly the type of profitable, reputable\r\n brand EcoPlus was designed to acquire,” said Alan Forbes, President and\r\n CEO of EcoPlus, Inc. “This transaction underscores our strategy of uniting\r\n high-quality nutraceutical companies under one public platform. Dr. Martin’s\r\n anti-aging formulations and long-standing customer relationships provide an\r\n ideal foundation for scalable growth. \r\n This acquisition will bring substantial revenue to EcoPlus.”\r\n\r\nFollowing the closing of the transaction, Longevity Formulas is expected\r\n to continue operations under its existing brand name. Dr. Martin will assist\r\n with product continuity and formulation integrity during the transition period.\r\n\r\nThis acquisition marks another step forward in EcoPlus’s broader roll-up\r\n strategy to consolidate high-margin, founder-led supplement and wellness\r\n brands. By leveraging shared manufacturing, compliance, and marketing\r\n infrastructure, EcoPlus seeks to deliver operational efficiency, enhance brand\r\n equity, and create long-term shareholder value.\r\n\r\nThe transaction is expected to close in the next quarter, subject to\r\n customary closing conditions.\r\n\r\n \r\n\r\nAbout Longevity Formulas, Inc....